SureGene
Skip to content
  • Home
  • Business Development
  • Scientific Approach
  • Personalized Medicine
  • Our Team
    • Management Team
    • Scientific Team
    • Investors
  • News
  • Contact Us

News

What’s New With SureGene

Press Release – November 9, 2010
SureGene Awarded Therapeutic Discovery Tax Credit to Support  Antipsychotic Biomarker Research

Press Release – November 9, 2010
SureGene Receives SBIR Matching Grant from Kentucky for  Genetic Biomarker Technology

The Pink Sheet – September 06, 2010
Antipsychotic Drugs Are Medco’s New Personalized Medicine Target

Pharmacogenomics Reporter – August 25, 2010
Medco, SureGene to Validate SULT4A1 Variants for Gauging Patient Response to Antipsychotic Drugs

Press Release – August 24, 2010
SureGene and the Medco Research Institute™ Enter a Collaboration to Evaluate the Ability of Genetic Biomarkers to Enhance Drug Selection for Serious Mental Health Illnesses.

Pharmacogenomics Reporter – April 14, 2010
With Medco Around for Dx Shops Developing PGx Tests Independently, Who Needs Pharma?

©2010 SureGene, LLC